Your browser doesn't support javascript.
loading
NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells.
Padoan, Benedetta; Casar, Christian; Krause, Jenny; Schultheiss, Christoph; Baumdick, Martin E; Niehrs, Annika; Zecher, Britta F; Pujantell, Maria; Yuki, Yuko; Martin, Maureen; Remmerswaal, Ester B M; Dekker, Tamara; van der Bom-Baylon, Nelly D; Noble, Janelle A; Carrington, Mary; Bemelman, Frederike J; van Lier, Rene A W; Binder, Mascha; Gagliani, Nicola; Bunders, Madeleine J; Altfeld, Marcus.
Afiliación
  • Padoan B; Research Department Virus Immunology, Leibniz Institute of Virology, 20251 Hamburg, Germany.
  • Casar C; Bioinformatics Core, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Krause J; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Center for Immunology, University of Minnesota, Minneapolis, MN, USA.
  • Schultheiss C; Division of Medical Oncology, University Hospital Basel, 4031 Basel, Switzerland; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, 4031 Basel, Switzerland.
  • Baumdick ME; Research Department Virus Immunology, Leibniz Institute of Virology, 20251 Hamburg, Germany; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Niehrs A; Research Department Virus Immunology, Leibniz Institute of Virology, 20251 Hamburg, Germany.
  • Zecher BF; Research Department Virus Immunology, Leibniz Institute of Virology, 20251 Hamburg, Germany; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Pujantell M; Research Department Virus Immunology, Leibniz Institute of Virology, 20251 Hamburg, Germany.
  • Yuki Y; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Martin M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Remmerswaal EBM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Dekker T; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van der Bom-Baylon ND; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Noble JA; Department of Pediatrics UCSF, Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA.
  • Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Ragon Institute of MGH, MIT and Harvard, Cambrid
  • Bemelman FJ; Renal Transplant Unit, Division of Internal Medicine, Academic Medical Centre, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van Lier RAW; University Medical Center Utrecht, Utrecht, the Netherlands.
  • Binder M; Division of Medical Oncology, University Hospital Basel, 4031 Basel, Switzerland; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, 4031 Basel, Switzerland.
  • Gagliani N; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Hamburg Center for Translational Immunology (HCTI), Hamburg, Germany.
  • Bunders MJ; Research Department Virus Immunology, Leibniz Institute of Virology, 20251 Hamburg, Germany; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Hamburg Center for Translational Immunology (HCTI), Hamburg, Germany.
  • Altfeld M; Research Department Virus Immunology, Leibniz Institute of Virology, 20251 Hamburg, Germany; Hamburg Center for Translational Immunology (HCTI), Hamburg, Germany. Electronic address: marcus.altfeld@leibniz-liv.de.
Cell Rep ; 43(4): 114089, 2024 Apr 23.
Article en En | MEDLINE | ID: mdl-38615318
ABSTRACT
Although natural killer (NK) cells are recognized for their modulation of immune responses, the mechanisms by which human NK cells mediate immune regulation are unclear. Here, we report that expression of human leukocyte antigen (HLA)-DP, a ligand for the activating NK cell receptor NKp44, is significantly upregulated on CD8+ effector T cells, in particular in human cytomegalovirus (HCMV)+ individuals. HLA-DP+ CD8+ T cells expressing NKp44-binding HLA-DP antigens activate NKp44+ NK cells, while HLA-DP+ CD8+ T cells not expressing NKp44-binding HLA-DP antigens do not. In line with this, frequencies of HLA-DP+ CD8+ T cells are increased in individuals not encoding for NKp44-binding HLA-DP haplotypes, and contain hyper-expanded CD8+ T cell clones, compared to individuals expressing NKp44-binding HLA-DP molecules. These findings identify a molecular interaction facilitating the HLA-DP haplotype-specific editing of HLA-DP+ CD8+ T cell effector populations by NKp44+ NK cells and preventing the generation of hyper-expanded T cell clones, which have been suggested to have increased potential for autoimmunity.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Linfocitos T CD8-positivos / Receptor 2 Gatillante de la Citotoxidad Natural Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Linfocitos T CD8-positivos / Receptor 2 Gatillante de la Citotoxidad Natural Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article